Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
about
Biomaterials for the Treatment of Alzheimer's DiseaseStepping back to move forward: a current review of iPSCs in the fight against Alzheimer's diseaseIn silico theoretical molecular modeling for Alzheimer's disease: the nicotine-curcumin paradigm in neuroprotection and neurotherapy.Nanoparticles in modern medicine: state of the art and future challenges.Polymeric nanoparticles for the drug delivery to the central nervous system.Nanotherapeutics for Alzheimer's disease (AD): Past, present and future.Protein fibrillation and nanoparticle interactions: opportunities and challenges.Critical assessment of implantable drug delivery devices in glaucoma management.Carriers in cell-based therapies for neurological disorders.Nanotechnology based theranostic approaches in Alzheimer's disease management: Current status and future perspective.Current status of treating neurodegenerative disease with induced pluripotent stem cells.Surface-engineered nanoliposomes by chelating ligands for modulating the neurotoxicity associated with β-amyloid aggregates of Alzheimer's disease.The administration of BDNF and GDNF to the brain via PLGA microparticles patterned within a degradable PEG-based hydrogel: Protein distribution and the glial response.Collagen for brain repair: therapeutic perspectives.Recent Status of Nanomaterial Fabrication and Their Potential Applications in Neurological Disease Management
P2860
Q26744462-06E7B8C4-9CD9-4299-96C5-07573BFE874EQ28073143-5510EF13-7241-4389-883D-D7CF54BDD067Q33826249-BFA3AA67-AC0E-4383-A660-A4F92E323DF1Q36920457-5E2F5A03-26AF-4E85-AF81-A548F0FDC7ACQ37076360-AFB79AC0-B2A1-40BA-972D-19F8C12FA698Q37948993-2E022300-0315-488D-A11E-EDA93C9F4DC4Q38086743-F943E7D6-E8E8-406F-8CB8-5438E1DC312FQ38143069-031940C1-6D09-4E52-8A9E-34D954E642A1Q38220613-2CB7F428-2015-410E-A3E6-C7CBDBC60D66Q38686370-62ADCF00-0699-4344-A9D6-80C8938D8290Q38691178-2BA73D63-0C92-41C5-905B-19DF3B51504BQ39348380-7BCC047A-7181-478F-95CB-E82EB8292FBBQ39604761-06176448-478C-49B2-83FE-CF330D5B39DCQ53513742-18B6087C-8835-49B8-A7DA-240FA4BF42FFQ57169956-75539968-F563-464F-99B7-7AA4FA5DAA03
P2860
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
@ast
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
@en
type
label
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
@ast
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
@en
prefLabel
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
@ast
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
@en
P1476
Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases.
@en
P2093
P304
P356
10.1016/J.IJPHARM.2005.09.040
P407
P577
2006-03-10T00:00:00Z